Literature DB >> 9017168

Psoriasis vulgaris with the early and late onset--HLA phenotype correlations.

A Szczerkowska-Dobosz1, W Placek, Z Szczerkowska, J Roszkiewicz.   

Abstract

The purpose of the study was to classify psoriasis vulgaris basing on HLA phenotype and the age of onset of the disease. One hundred fifteen psoriatic patients were included into the study and divided into two groups: group I--with early onset (< 40 years) and group II--with late onset (> or = 40 years). Each group was subclassified according to Cw6 antigen expression: IA-Cw(6+)--early onset, IB-Cw(6-)--early onset, IIA-Cw(6+)--late onset, IIB-Cw(6-)--late onset. HLA class I antigen typing was performed in each of 115 subjects using the microlymphocytotoxicity test. HLA class II antigen typing was also performed in 20 randomly selected patients by means of the two-step microlymphocytotoxicity test. The occurrence Cw6, B13, B17 antigens was significantly increased in psoriatic groups in comparison with a control population. No difference between the groups was found with respect to class II antigen frequency. Cw6, B13 and B17 were the most specific markers for psoriasis with the early onset, whereas B27, Cw2, B44 and Cw5 seemed to be associated with the late type of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9017168

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  2 in total

1.  Lack of association of HLA-C alleles with late-onset psoriasis in the northern Polish population.

Authors:  Aneta Szczerkowska-Dobosz; Katarzyna Niespodziana; Krzysztof Rebała; Joanna Garstecka; Magdalena Lange; Wioletta Barańska-Rybak
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

2.  HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Peter Kozub; Mária Zilínková; Peter Frey; Stanislav Ferenčík; Milan Buc
Journal:  Folia Microbiol (Praha)       Date:  2012-11-27       Impact factor: 2.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.